Sildenafil Teva
From £3.99
Clinical Evidence Supporting Sildenafil Treatment
Landmark Clinical Studies
The foundation of sildenafil's evidence base stems from pivotal Phase III trials conducted in the 1990s. These randomised, double-blind, placebo-controlled studies involved over 4,000 men with erectile dysfunction of various causes. Results consistently demonstrated that sildenafil significantly improved erectile function compared to placebo, with success rates ranging from 70-85% depending on the underlying cause of ED.
Effectiveness Across Different Patient Groups
Research has established sildenafil's efficacy across diverse patient populations. Studies in men with diabetes-related ED showed improvement in approximately 60-70% of participants. In patients with cardiovascular disease, carefully supervised trials demonstrated both effectiveness and cardiovascular safety when used appropriately. Men with psychological causes of ED showed particularly high response rates, often exceeding 80% in clinical studies.
Dosage Optimisation Research
Clinical evidence supports flexible dosing with sildenafil, typically starting at 50mg and adjusting based on individual response and tolerability. Studies comparing 25mg, 50mg, and 100mg doses show that whilst higher doses may increase effectiveness, they also increase the likelihood of side effects. Research indicates that approximately 80% of men find their optimal dose within the first few attempts, highlighting the importance of working with healthcare providers to find the best approach.
Generic vs Branded Studies
Bioequivalence studies have consistently demonstrated that generic sildenafil performs identically to branded Viagra in terms of therapeutic effect. These studies measure drug absorption, distribution, and elimination, confirming that generic versions contain the same active ingredient in equivalent amounts. This research supports why many patients choose generic sildenafil as a cost-effective alternative, with EverydayMeds offering both options to provide patient choice.
Long-term Safety and Effectiveness Data
Extended follow-up studies spanning several years have confirmed sildenafil's sustained effectiveness and acceptable safety profile. Research shows that men who respond initially to treatment typically maintain their response over time. Long-term studies also demonstrate that side effects generally remain mild and often diminish with continued use, as patients become accustomed to the medication.
Real-world Evidence and Patient Satisfaction
Post-marketing surveillance and real-world studies complement clinical trial data by providing insights into how sildenafil performs in everyday practice. These studies consistently show high patient satisfaction rates and confirm the safety profile established in controlled trials. Real-world evidence also demonstrates that proper patient selection and clinical assessment are crucial for optimal outcomes.
